Clear Street Initiates Editas Medicine(EDIT.US) With Buy Rating, Announces Target Price $4

Futu NewsDec 19 18:36 · Ratings

Evercore Maintains Editas Medicine(EDIT.US) With Buy Rating, Cuts Target Price to $5

Futu NewsDec 16 21:33 · Ratings

Evercore ISI Group Maintains Outperform on Editas Medicine, Lowers Price Target to $5

BenzingaDec 16 21:29 · Ratings

J.P. Morgan Downgrades Editas Medicine(EDIT.US) to Sell Rating

Futu NewsDec 16 19:32 · Ratings

Analysts Offer Insights on Healthcare Companies: Affimed (AFMD), Editas Medicine (EDIT) and Trevi Therapeutics (TRVI)

TipRanksDec 16 14:10 · Ratings

Express News | Editas Medicine Inc : JP Morgan Cuts to Underweight From Neutral

BreakingsDec 16 13:24